EF Hutton Assumes Ocean Biomedical at Buy, Announces Price Target of $17
Portfolio Pulse from Benzinga Newsdesk
EF Hutton analyst Tony Butler assumes Ocean Biomedical (NASDAQ:OCEA) with a Buy rating and announces a price target of $17.
May 25, 2023 | 11:16 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ocean Biomedical (NASDAQ:OCEA) receives a Buy rating from EF Hutton analyst Tony Butler, with a price target of $17.
The Buy rating and price target announcement by EF Hutton analyst Tony Butler is likely to have a positive short-term impact on Ocean Biomedical's stock price. Investors may see this as a signal of confidence in the company's potential, leading to increased demand for the stock and a potential price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100